Skip to content
LexBuild

Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting

---
identifier: "/us/fr/03-11533"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "03-11533"
section_name: "Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting"
positive_law: false
currency: "2003-05-09"
last_updated: "2003-05-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-11533"
document_type: "notice"
publication_date: "2003-05-09"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "68 FR 25047"
fr_volume: 68
---

#  Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.

*Name:* Healthcare Infection Control Practices Advisory Committee.

*Times and Dates:* 8:30 a.m.-5 p.m., June 2, 2003. 8:30 a.m.-4 p.m., June 3, 2003.

*Place:* Centers for Disease Control and Prevention, Building 17, Rooms 1039/1041, 1600 Clifton Road, NE, Atlanta, Georgia 30333.

*Status:* Open to the public, limited only by the space available.

*Purpose:* The committee is charged with providing advice and guidance to the Secretary; the Assistant Secretary for Health; the Director, CDC; and the Director, National Center for Infectious Diseases (NCID), regarding (1) the practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections ( *e.g.* , nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and

(3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions.

*Matters to be Discussed:* Agenda items will include a review of the Draft Guideline for Preventing Transmission of Infectious Agents in Healthcare Settings (formerly Guideline Isolation Precautions in Hospitals); infection control issues related to Severe Acute Respiratory Syndrome (SARS); strategies for prevention of surgical site infections; and updates on CDC activities of interest to the committee.

Agenda items are subject to change as priorities dictate.

*Contact Person for More Information:* Michele L. Pearson, M.D., Executive Secretary, HICPAC, Division of Healthcare Quality Promotion, NCID, CDC, 1600 Clifton Road, NE, M/S A-07, Atlanta, Georgia 30333, telephone 404/498-1182.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: May 2, 2003.

Diane C. Allen,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.